Le Bonheur Neuroscience Institute Database

Overview

About this study

The purpose of this study is to serve as a tool for collecting and reporting healthcare outcomes data for patients with Epilepsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subject must have been admitted or treated within the Neuroscience Institute.
  • Subject must have diagnosis of epilepsy, brain tumor, and/or other neurological disorders.
  • Male or female.

Exclusion Criteria:

  • Subject does not have diagnosis of epilepsy, brain tumor, and/or neurological condition.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 11/27/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Donnie Starnes, M.D.

Contact us for the latest status

Contact information:

Precylla Ruiz

(507) 538-6606

Ruiz.Precylla@mayo.edu

More information

Publications

Publications are currently not available